FDA Updates List of Valsartan Blood Pressure Medication Affected by Recall

August 13, 2018 - pharmaceutical

World health agencies have expanded their lists of recalled blood pressure medications after two more manufacturers, one based in China and one based in India, were found to have potentially tainted batches of the drugs with a probable human carcinogen.

On August 9, the U.S. Food and Drug Administration (FDA) issued an updated list of blood pressure medication affected by the recent recall of valsartan products. The agency issued a list of recalled drugs following an investigation that revealed that certain blood pressure medications contained N-nitrosodimethylamine (NDMA), a probable human carcinogen. The list now includes products from Camber Pharmaceuticals Inc., manufactured by Hetero Labs Limited in India. Tests of these newest drugs revealed that they contained NDMA beyond acceptable levels, albeit in lower amounts than the drugs subject to the recall earlier.

The agency has contacted additional manufacturers of valsartan to determine whether their practices may have introduced the suspected carcinogen. Patients should consult with their doctor before they stop taking any medications as not all valsartan products were affected by the voluntary recall. The FDA will provide more information about the recalls as it becomes available.

Patients have filed lawsuits in the wake of the FDA recall, claiming that the pharmaceutical companies failed to warn them about the potential carcinogen. Patients exposed to potentially dangerous levels of NDMA say that the contaminated drugs could have contributed to their liver cancer, lung cancer or kidney cancer.


Free Case Evaluation

Get in touch with our lawyers for a free and confidential case review by calling us toll free at 1 (888) 402-5552 or by filling out the form below.

DISCLAIMER: No attorney client relationship will exist between you and our firm until we enter into a signed Retainer/Services Agreement. Completion of this document is for informational purposes only and does not constitute a Retainer/Services Agreement. The information you obtain at this site is not, nor is it intended to be, legal advice. Contacting us does not create an attorney-client relationship. In some jurisdictions this website may be considered lawyer advertising. You should consult an attorney for advice regarding your individual situation. Click here for more information.


Back To More Articles